[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1020167A1 - Oxa acids and related compounds for treating skin conditions. - Google Patents

Oxa acids and related compounds for treating skin conditions.

Info

Publication number
HK1020167A1
HK1020167A1 HK99103629A HK99103629A HK1020167A1 HK 1020167 A1 HK1020167 A1 HK 1020167A1 HK 99103629 A HK99103629 A HK 99103629A HK 99103629 A HK99103629 A HK 99103629A HK 1020167 A1 HK1020167 A1 HK 1020167A1
Authority
HK
Hong Kong
Prior art keywords
related compounds
skin conditions
treating skin
oxa acids
oxa
Prior art date
Application number
HK99103629A
Other languages
English (en)
Inventor
Dmitri Ptchelintsev
Neil Scancarella
Robert Kalafsky
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of HK1020167A1 publication Critical patent/HK1020167A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24—Thermal properties
    • A61K2800/244—Endothermic; Cooling; Cooling sensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK99103629A 1996-06-04 1999-08-23 Oxa acids and related compounds for treating skin conditions. HK1020167A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/658,089 US5847003A (en) 1996-06-04 1996-06-04 Oxa acids and related compounds for treating skin conditions
PCT/US1997/009281 WO1997046231A1 (fr) 1996-06-04 1997-06-02 Acides oxa et composes apparentes utilises dans le traitement d'etats dermatologiques

Publications (1)

Publication Number Publication Date
HK1020167A1 true HK1020167A1 (en) 2000-03-31

Family

ID=24639855

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103629A HK1020167A1 (en) 1996-06-04 1999-08-23 Oxa acids and related compounds for treating skin conditions.

Country Status (11)

Country Link
US (5) US5847003A (fr)
EP (1) EP0910362B1 (fr)
JP (2) JPH1072334A (fr)
CN (1) CN1110302C (fr)
AR (1) AR008384A1 (fr)
AT (1) ATE280577T1 (fr)
BR (1) BR9709427B1 (fr)
CA (1) CA2256582C (fr)
DE (1) DE69731385T2 (fr)
HK (1) HK1020167A1 (fr)
WO (1) WO1997046231A1 (fr)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5932229A (en) * 1996-04-25 1999-08-03 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
EP1709960A3 (fr) * 1998-02-13 2006-12-20 Carol J. Buck Utilisation de compositions contenant des acides alcanoiques pour défriser les cheveux
CA2323364A1 (fr) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions pour modifier l'aspect exterieur de la peau
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6607716B1 (en) 1998-09-29 2003-08-19 Tech Labs, Inc. Pediculicidal compositions, a kit, and methods of use
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6696078B1 (en) * 1999-07-21 2004-02-24 Edwin J. Masters System and methods for local intradermal treatment
US6309662B1 (en) 1999-09-23 2001-10-30 Janet Buchanan Use of anti-inflammatory drugs for treatment of dermatological conditions
US6358517B1 (en) 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
US6277362B1 (en) 1999-10-26 2001-08-21 Isw, Inc. After shave treatment preparation
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US20030072724A1 (en) * 1999-12-16 2003-04-17 Maibach Howard I. Topical pharmaceutical composition to treat hyperpigmentation of the skin
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6562370B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US6562369B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US8883856B2 (en) * 2000-02-28 2014-11-11 John Jackson Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
FR2811567B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
FR2812812B1 (fr) * 2000-08-08 2002-10-11 Philippe Gorny Medicament destine notamment a combattre les dysfonctions sexuelles
JP3573287B2 (ja) * 2000-08-08 2004-10-06 第一製薬株式会社 高吸収性固形製剤
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
US20030095991A1 (en) * 2000-10-02 2003-05-22 Curtis Cole Treatment for skin
US20040213754A1 (en) * 2000-10-02 2004-10-28 Cole Curtis A. Method for cleansing sensitive skin using an alkanolamine
US20040067245A1 (en) 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US6565864B2 (en) 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
EP1234572B1 (fr) * 2001-02-26 2013-10-30 Mibelle AG Cosmetics Produits de soin pour la peau contenant de l'isoflavone aglycone
DE10111040A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus alpha-Liponsäure und dermatologisch verträglichen Substanzen, die Lichtabsorption im UV-A-Bereich und/oder UV-B-Bereich zeigen, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
DE10111046A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus alpha-Liponsäure und dermatologisch verträglichen Substanzen, die Lichtabsorption im UV-A-Bereich und/oder UV-B-Bereich zeigen,zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
WO2002096374A2 (fr) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Préparations et procédés dermatologiques
US6419940B1 (en) * 2001-08-14 2002-07-16 Denver Blanton Denver's sting stopper
US6514508B1 (en) * 2001-08-24 2003-02-04 Jeffrey Rose Itch reducing device and method
US6641824B2 (en) * 2001-11-09 2003-11-04 Avon Products, Inc. Skin treatment using a new retinoid
US20050238730A1 (en) * 2001-11-21 2005-10-27 Agnes Le Fur Compositions comprising an ethanolamine derivative and organic metal salts
US20030157137A1 (en) * 2001-12-19 2003-08-21 Alwyn Company, Inc. Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol
US20030180250A1 (en) * 2002-03-22 2003-09-25 Council Of Scientific And Industrial Research Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents
US6835385B2 (en) 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
US6858215B2 (en) 2002-06-14 2005-02-22 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
WO2004000259A1 (fr) * 2002-06-21 2003-12-31 Dermatrends, Inc. Administration topique de bases actives du point de vue pharmacologique et destinees a eclaircir la peau
KR20040043703A (ko) * 2002-11-16 2004-05-27 (주)라렌드몽드 레티노이드를 함유한 화학 박피제
US6866856B2 (en) * 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
US7060303B2 (en) * 2002-12-31 2006-06-13 Avon Products, Inc. Use of purslane to treat facial wrinkles
ES2543082T3 (es) 2002-12-31 2015-08-14 Bsn Medical Gmbh Apósito para heridas
WO2004105719A2 (fr) * 2003-05-23 2004-12-09 Ninapharm (S.A.R.L) Produit destine a la protection de l’epiderme
US7085154B2 (en) * 2003-06-03 2006-08-01 Samsung Electronics Co., Ltd. Device and method for pulse width control in a phase change memory device
DK1675536T3 (en) 2003-09-17 2016-04-18 Bsn Medical Gmbh WOUND COMPOUND AND PROCEDURE FOR PREPARING IT
US7531711B2 (en) 2003-09-17 2009-05-12 Ossur Hf Wound dressing and method for manufacturing the same
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US7842007B2 (en) 2004-04-30 2010-11-30 Clawson Burrell E Apparatus and methods for isolating human body areas for localized cooling
US20060040002A1 (en) * 2004-08-17 2006-02-23 Boitano Suzanne M Anti-itch composition
US7351745B2 (en) 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
US8221766B2 (en) * 2004-12-22 2012-07-17 Avon Products, Inc. Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
US7618662B2 (en) 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
US7410658B2 (en) * 2004-12-22 2008-08-12 Avon Products, Inc. Use of Alisma orientale in cosmetics and compositions thereof
US7514092B2 (en) * 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
US7161056B2 (en) * 2005-01-28 2007-01-09 Ossur Hf Wound dressing and method for manufacturing the same
US20060235370A1 (en) * 2005-04-04 2006-10-19 Oblong John E Method of regulating mammalian keratinous tissue
CA2612408A1 (fr) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Composition pharmaceutique comprenant de l'extrait de mahonia aquifolium pour le traitement du psoriasis
US20070027153A1 (en) * 2005-07-27 2007-02-01 Reeth Kevin M Topical skin-protectant and anti-pruritic compositions
US20070027152A1 (en) * 2005-07-27 2007-02-01 Clark Kathleen L Topical anti-pruritic compositions and methods of action of same
US7989554B2 (en) * 2006-01-10 2011-08-02 Enzon Pharmaceuticals, Inc. Reacting polyalkylene oxide with base, tertiary alkyl haloacetate, then acid to prepare polyalkylene oxide carboxylic acid
FR2908307B1 (fr) * 2006-11-10 2009-05-01 Oreal Composition cosmetique comprenant un phosphate d'alkyle et un ether d'alcool gras et de polyethyleneglycol, procedes et utilisations.
WO2008058333A1 (fr) * 2006-11-15 2008-05-22 Arthritis Relief Plus Ltd Formulation topique et ses utilisations
US20080220026A1 (en) * 2007-03-06 2008-09-11 Prithwiraj Maitra Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces
US7642062B2 (en) 2006-12-29 2010-01-05 Avon Products Inc. Compositions and methods of their use for improving the condition and appearance of skin
US8586012B2 (en) * 2007-06-06 2013-11-19 Solise LLC Body wash with sunscreen system and method
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
WO2009002913A1 (fr) * 2007-06-22 2008-12-31 Avicena Group, Inc. Utilisation de composés de créatine pour traiter une dermatite
RS52576B (en) * 2007-11-07 2013-04-30 Gojko DUNKIĆ CHEMICAL PREPARATION FOR THE SUCCESSFUL REMOVAL OF BENIG LESIONS AND THE PROCEDURE OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US8299127B2 (en) * 2009-03-11 2012-10-30 Conopco, Inc. Method and composition for evenly applying water soluble actives
US8173108B2 (en) 2009-11-04 2012-05-08 Conopco, Inc. Sunscreen composition
US8206691B2 (en) 2009-11-04 2012-06-26 Conopco, Inc. Sunscreen composition with fatty acid alkanolamides
US8329149B2 (en) 2009-12-30 2012-12-11 Avon Products, Inc. Topical lightening composition and uses thereof
EP2588062B1 (fr) 2010-06-30 2019-05-29 Avon Products, Inc. Utilisation de tiliacora triandra en cosmétique et compositions en contenant
BR112012032082B1 (pt) 2010-06-30 2019-11-26 Avon Products, Inc. Composição e método cosmético para melhorar a aparência estética da pele humana
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs
US8974548B2 (en) 2011-09-26 2015-03-10 Conopco, Inc. Hair composition
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
EP2855619B1 (fr) * 2012-07-26 2019-04-17 Amril AG Esters pour émulsions de forage et fluides de traitement des métaux
AU2014276460A1 (en) 2013-06-04 2015-12-24 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
ES2539520B1 (es) * 2013-12-30 2016-06-06 Laboratorios Viñas S.A. Composición farmacéutica de aplicación tópica en forma de suspensión de micronizado y método y usos correspondientes
US9642788B2 (en) 2014-04-25 2017-05-09 The Procter & Gamble Company Shampoo composition comprising gel matrix and histidine
US9642787B2 (en) 2014-04-25 2017-05-09 The Procter & Gamble Company Method of inhibiting copper deposition on hair
US9586063B2 (en) 2014-04-25 2017-03-07 The Procter & Gamble Company Method of inhibiting copper deposition on hair
BR112018008556A2 (pt) 2015-10-30 2018-10-23 Patagonia Pharmaceuticals Llc ?composições farmacêuticas e métodos para tratar ictiose congênita?
WO2017139457A1 (fr) * 2016-02-11 2017-08-17 Ohio University Compositions et méthodes pour inhiber les dommages par rayonnement uvb par ciblage d'oxyde nitrique synthases constitutives (cnos)
JP6835707B2 (ja) 2016-04-05 2021-02-24 株式会社Moresco オキサ酸化合物
US11786447B2 (en) 2016-06-30 2023-10-17 The Procter & Gamble Company Conditioner composition comprising a chelant
US11246816B2 (en) 2016-06-30 2022-02-15 The Procter And Gamble Company Shampoo compositions comprising a chelant
US20180000706A1 (en) * 2016-06-30 2018-01-04 The Procter & Gamble Company Conditioner Composition Comprising a Chelant
US20180000715A1 (en) 2016-06-30 2018-01-04 The Procter & Gamble Company Hair Care Compositions For Calcium Chelation
US20180000705A1 (en) 2016-06-30 2018-01-04 The Procter & Gamble Company Shampoo Compositions Comprising a Chelant
BE1025004B1 (nl) 2017-02-24 2018-09-24 Oystershell Nv Afpelbare nagellak
WO2018202832A1 (fr) 2017-05-05 2018-11-08 Firmenich Sa Réduction d'hydroperoxyde organique dans des matières premières de parfumerie et des matières premières alimentaires
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
BR112021000724A2 (pt) 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20230346664A1 (en) * 2022-04-28 2023-11-02 L'oreal Compositions suitable as setters
NL2035417B9 (en) 2022-07-19 2024-10-09 Coty Inc Cosmetic composition

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342858A (en) * 1964-08-20 1967-09-19 Allied Chem Preparation of alkoxy-alkanoic acids by the oxidation of alkoxy-alkanols
DE2404047A1 (de) * 1974-01-29 1975-08-14 Henkel & Cie Gmbh Hautpflege- und hautschutzmittel mit einem gehalt an haut-feuchthaltemitteln
GB1541463A (en) * 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
DE2714564C2 (de) * 1977-04-01 1986-01-02 Chemische Werke Hüls AG, 4370 Marl Verfahren zur Herstellung von cyclischen Diestern der Undecandisäure
IT1114950B (it) * 1977-12-30 1986-02-03 Porro Marcella Composizioni per il trattamento e la terapia di acne
US4386104A (en) * 1977-04-19 1983-05-31 Nazzaro Porro Marcella Process for the treatment of acne
DE2936123C2 (de) * 1979-09-07 1987-04-09 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung von Alkoxyessigsäuren
US4721579A (en) * 1980-08-15 1988-01-26 Basf Corporation Sodium carboxymethyl derivatives of polyoxyalkylene glycols, their production, and use in functional fluids
US4766153A (en) * 1986-04-30 1988-08-23 Sandoz Ltd. Alkyl polyoxyalkylene carboxylate esters and skin care compositions containing the same
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US4960764A (en) * 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
US4885282A (en) * 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
DE3811081A1 (de) * 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
US4916206A (en) * 1988-11-14 1990-04-10 Olin Corporation Nitramine-containing homopolymers and co-polymers and a process for the preparation thereof
US5008443A (en) * 1988-11-14 1991-04-16 Olin Corporation Process for the preparation of nitramine-containing homopolymers and co-polymers
DE3901279A1 (de) * 1989-01-18 1990-07-19 Hoechst Ag Verwendung von polyamidoaminen als haerter fuer epoxidharze und diese enthaltende haertbare mischungen
DE3903663C1 (fr) * 1989-02-08 1990-09-27 Huels Ag, 4370 Marl, De
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
JPH03109498A (ja) * 1989-09-25 1991-05-09 Kanebo Ltd 低刺激性洗浄剤組成物
GB9003201D0 (en) * 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
DE4206392A1 (de) * 1992-02-29 1993-09-02 Hoechst Ag Haertungsmittel fuer epoxidharze
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
JP3376687B2 (ja) * 1994-05-24 2003-02-10 味の素株式会社 洗浄剤組成物
US5464929A (en) * 1995-03-06 1995-11-07 Ethicon, Inc. Absorbable polyoxaesters
US5639897A (en) * 1995-12-07 1997-06-17 O'lenick, Jr.; Anthony J. Amido ether amine amphoteric surfactants
JP2000512663A (ja) * 1996-02-21 2000-09-26 ジボーダン―ルール（アンテルナシヨナル）ソシエテ アノニム フレイグランス先駆体
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
JP3109498B2 (ja) 1998-11-10 2000-11-13 日本電気株式会社 電波探知方法及び電波探知装置

Also Published As

Publication number Publication date
EP0910362B1 (fr) 2004-10-27
US20020040056A1 (en) 2002-04-04
US6333356B1 (en) 2001-12-25
ATE280577T1 (de) 2004-11-15
AR008384A1 (es) 2000-01-19
DE69731385T2 (de) 2006-02-02
US6071962A (en) 2000-06-06
CN1221342A (zh) 1999-06-30
EP0910362A1 (fr) 1999-04-28
BR9709427B1 (pt) 2009-05-05
US6069169A (en) 2000-05-30
BR9709427A (pt) 2000-01-11
US6534543B2 (en) 2003-03-18
EP0910362A4 (fr) 1999-12-22
US5847003A (en) 1998-12-08
WO1997046231A1 (fr) 1997-12-11
CA2256582A1 (fr) 1997-12-11
JPH1072334A (ja) 1998-03-17
JP2000511900A (ja) 2000-09-12
CN1110302C (zh) 2003-06-04
DE69731385D1 (de) 2004-12-02
CA2256582C (fr) 2008-08-12

Similar Documents

Publication Publication Date Title
HK1020167A1 (en) Oxa acids and related compounds for treating skin conditions.
ZA971937B (en) Combinations for treatment of proliferative diseases.
ZA96740B (en) Skin treatment composition
ZA949344B (en) Treatment of poultry.
EP0784598A4 (fr) Traitement des eaux enrichies en matieres nutritives
GB9411080D0 (en) Treatment
ZA977902B (en) Fatty acid treatment
AU7582398A (en) Composition for treating skin conditions
ZA952356B (en) Skin treatment composition
ZA97986B (en) Treatment of liquors.
EP0612513A3 (en) External skin treatment composition.
GB9605828D0 (en) Treatment method
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA978226B (en) Fatty acid treatment.
ZA974421B (en) Method of improving skin condition.
GB9405021D0 (en) Skin treatment composition
ZA976350B (en) Treatment of liquid.
GB9606076D0 (en) Diabetes treatment
ZA977867B (en) Method of treatment.
GB9416410D0 (en) Effluent treatment
GB9405046D0 (en) Skin treatment composition
ZA978139B (en) Process for the biological-thermal treatment of waste.
GB9610456D0 (en) Paper treatment
GB9619061D0 (en) Farm effluent treatment
ZA979052B (en) Fatty acid treatment.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150602